• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of biochemjBJ Latest papers and much more!
Biochem J. Dec 1, 1989; 264(2): 475–481.
PMCID: PMC1133604

The specificity of bovine spleen cathepsin S. A comparison with rat liver cathepsins L and B.


The peptide-bond-specificity of bovine spleen cathepsin S in the cleavage of the oxidized insulin B-chain and peptide methylcoumarylamide substrates was investigated and the results are compared with those obtained with rat liver cathepsins L and B. Major cleavage sites in the oxidized insulin B-chain generated by cathepsin S are the bonds Glu13-Ala14, Leu17-Val18 and Phe23-Tyr26; minor cleavage sites are the bonds Asn3-Gln4, Ser9-His10 and Leu15-Tyr16. The bond-specificity of this proteinase is in part similar to the specificities of cathepsin L and cathepsin N. Larger differences are discernible in the reaction with synthetic peptide substrates. Cathepsin S prefers smaller neutral amino acid residues in the subsites S2 and S3, whereas cathepsin L efficiently hydrolyses substrates with bulky hydrophobic residues in the P2 and P3 positions. The results obtained from inhibitor studies differ somewhat from those based on substrates. Z-Phe-Ala-CH2F (where Z- represents benzyloxycarbonyl-) is a very potent time-dependent inhibitor for cathepsin S, and inhibits this proteinase 30 times more efficiently than it does cathepsin L and about 300 times better than it does cathepsin B. By contrast, the peptidylmethanes Z-Val-Phe-CH3 and Z-Phe-Lys(Z)-CH3 inhibit competitively both cathepsin S and cathepsin L in the micromolar range.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Bauer CA. The active centers of Streptomyces griseus protease 3 and alpha-chymotrypsin. Enzyme-substrate interactions beyond subsite S'1. Biochim Biophys Acta. 1976 Jul 8;438(2):495–502. [PubMed]
  • Barrett AJ, Kirschke H. Cathepsin B, Cathepsin H, and cathepsin L. Methods Enzymol. 1981;80(Pt 100):535–561. [PubMed]
  • Barrett AJ, Kembhavi AA, Brown MA, Kirschke H, Knight CG, Tamai M, Hanada K. L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochem J. 1982 Jan 1;201(1):189–198. [PMC free article] [PubMed]
  • Brömme D, Peters K, Fink S, Fittkau S. Enzyme-substrate interactions in the hydrolysis of peptide substrates by thermitase, subtilisin BPN', and proteinase K. Arch Biochem Biophys. 1986 Feb 1;244(2):439–446. [PubMed]
  • Brömme D, Bartels B, Kirschke H, Fittkau S. Peptide methyl ketones as reversible inhibitors of cysteine proteinases. J Enzyme Inhib. 1989;3(1):13–21. [PubMed]
  • Brömme D, Bescherer K, Kirschke H, Fittkau S. Enzyme-substrate interactions in the hydrolysis of peptides by cathepsins B and H from rat liver. Biochem J. 1987 Jul 15;245(2):381–385. [PMC free article] [PubMed]
  • Eulitz M, Götze D, Hilschmann N. Die Primärstruktur einer humanen Immunglobulin-L-Kette vom kappa-Typ (Bence-Jones-Protein Scw.), I. Tryptische Peptide. Hoppe Seylers Z Physiol Chem. 1974 Jul;355(7):819–841. [PubMed]
  • Evans P, Etherington DJ. Action of cathepsin N on the oxidized B-chain of bovine insulin. FEBS Lett. 1979 Mar 1;99(1):55–58. [PubMed]
  • Gal S, Gottesman MM. The major excreted protein (MEP) of transformed mouse cells and cathepsin L have similar protease specificity. Biochem Biophys Res Commun. 1986 Aug 29;139(1):156–162. [PubMed]
  • Kärgel HJ, Dettmer R, Etzold G, Kirschke H, Bohley P, Langner J. Action of cathepsin L on the oxidized B-chain of bovine insulin. FEBS Lett. 1980 Jun 2;114(2):257–260. [PubMed]
  • Kirschke H, Langner J, Wiederanders B, Ansorge S, Bohley P. Cathepsin L. A new proteinase from rat-liver lysosomes. Eur J Biochem. 1977 Apr 1;74(2):293–301. [PubMed]
  • Kirschke H, Locnikar P, Turk V. Species variations amongst lysosomal cysteine proteinases. FEBS Lett. 1984 Aug 20;174(1):123–127. [PubMed]
  • Kirschke H, Schmidt I, Wiederanders B. Cathepsin S. The cysteine proteinase from bovine lymphoid tissue is distinct from cathepsin L (EC Biochem J. 1986 Dec 1;240(2):455–459. [PMC free article] [PubMed]
  • Kirschke H, Pepperle M, Schmidt I, Wiederanders B. Are there species differences amongst the lysosomal cysteine proteinases? Biomed Biochim Acta. 1986;45(11-12):1441–1446. [PubMed]
  • Kirschke H, Wiederanders B, Brömme D, Rinne A. Cathepsin S from bovine spleen. Purification, distribution, intracellular localization and action on proteins. Biochem J. 1989 Dec 1;264(2):467–473. [PMC free article] [PubMed]
  • Maciewicz RA, Etherington DJ. A comparison of four cathepsins (B, L, N and S) with collagenolytic activity from rabbit spleen. Biochem J. 1988 Dec 1;256(2):433–440. [PMC free article] [PubMed]
  • Mason RW. Species variations amongst lysosomal cysteine proteinases. Biomed Biochim Acta. 1986;45(11-12):1433–1440. [PubMed]
  • Mason RW, Taylor MA, Etherington DJ. The purification and properties of cathepsin L from rabbit liver. Biochem J. 1984 Jan 1;217(1):209–217. [PMC free article] [PubMed]
  • Mason RW, Green GD, Barrett AJ. Human liver cathepsin L. Biochem J. 1985 Feb 15;226(1):233–241. [PMC free article] [PubMed]
  • McKay MJ, Offermann MK, Barrett AJ, Bond JS. Action of human liver cathepsin B on the oxidized insulin B chain. Biochem J. 1983 Aug 1;213(2):467–471. [PMC free article] [PubMed]
  • Rasnick D. Synthesis of peptide fluoromethyl ketones and the inhibition of human cathepsin B. Anal Biochem. 1985 Sep;149(2):461–465. [PubMed]
  • Rauber P, Angliker H, Walker B, Shaw E. The synthesis of peptidylfluoromethanes and their properties as inhibitors of serine proteinases and cysteine proteinases. Biochem J. 1986 Nov 1;239(3):633–640. [PMC free article] [PubMed]
  • Schechter I, Berger A. On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun. 1967 Apr 20;27(2):157–162. [PubMed]
  • Schiltz E, Schnackerz KD, Gracy RW. Comparison of ninhydrin, fluorescamine, and o-phthaldialdehyde for the detection of amino acids and peptides and their effects on the recovery and composition of peptides from thin-layer fingerprints. Anal Biochem. 1977 May 1;79(1-2):33–41. [PubMed]
  • Smith RA, Copp LJ, Donnelly SL, Spencer RW, Krantz A. Inhibition of cathepsin B by peptidyl aldehydes and ketones: slow-binding behavior of a trifluoromethyl ketone. Biochemistry. 1988 Aug 23;27(17):6568–6573. [PubMed]
  • Thompson RC, Blout ER. Restrictions on the binding of proline-containing peptides to elastase. Biochemistry. 1973 Jan 2;12(1):51–57. [PubMed]
  • Tian WX, Tsou CL. Determination of the rate constant of enzyme modification by measuring the substrate reaction in the presence of the modifier. Biochemistry. 1982 Mar 2;21(5):1028–1032. [PubMed]
  • Turnsek T, Kregar I, Lebez D. Acid sulphydryl protease from calf lymph nodes. Biochim Biophys Acta. 1975 Oct 22;403(2):514–520. [PubMed]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...